Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Peonidin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 known ✓ | P27487 | 3/20 | 0.74 |
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.74 |
| ▸ | EGFR known ✓ | P00533 | 2/20 | 0.56 |
| ▸ | KDR known ✓ | P35968 | 2/20 | 0.56 |
| ▸ | MAOB known ✓ | P27338 | 1/20 | 0.41 |
| ▸ | CD38 | P28907 | 11/20 | 0.95 |
| ▸ | GLO1 | Q04760 | 5/20 | 0.68 |
| ▸ | SNCA | P37840 | 3/20 | 0.68 |
| ▸ | F2 | P00734 | 1/20 | 0.66 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.66 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.66 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | EP300 | Q09472 | 2/20 | 0.56 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Peonidin SCHEMBL29403736 | 0.99 | CD38 (0.97) | CD38DPP4MAOAGLO1SNCA | |
| Peonidin SCHEMBL20016 | 0.99 | CD38 (0.97) | CD38DPP4MAOAGLO1SNCA | |
| Peonidin SCHEMBL29394353 | 0.97 | CD38 (1.00) | CD38DPP4MAOAGLO1SNCA | |
| Peonidin SCHEMBL20017 | 0.97 | CD38 (1.00) | CD38DPP4MAOAGLO1SNCA | |
| Peonidin SCHEMBL30891536 | 0.97 | CD38 (1.00) | CD38DPP4MAOAGLO1SNCA | |
| Petunidin SCHEMBL8500875 | 0.91 | CD38 (0.82) | CD38DPP4MAOAGLO1SNCA | |
| SCHEMBL29383042 | 0.89 | CD38 (0.85) | CD38DPP4MAOAGLO1SNCA | |
| Malvidin SCHEMBL8504053 | 0.86 | CD38 (0.83) | CD38DPP4MAOAGLO1SNCA | |
| Petunidin SCHEMBL9120043 | 0.85 | CD38 (0.95) | CD38DPP4MAOAGLO1SNCA | |
| Malvidin SCHEMBL30683334 | 0.85 | DPP4 (1.00) | CD38DPP4MAOAGLO1SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10441602-B2 | Human gastrointestinal microbiome modulating composition and methods of use | MICROBIOME THERAPEUTICS, LLC (US) | 2019-10-15 | — | — | US | claimed |
| US-20170360673-A1 | HAIR COMPOSITION | CONOPCO, INC., D/B/A UNILEVER (US) | 2017-12-21 | — | — | US | claimed |
| EP-3236927-A1 | HAIR COMPOSITION | Unilever PLC (GB) | 2017-11-01 | — | — | EP | claimed |
| CN-107106628-A | Hair composition | 荷兰联合利华有限公司 | 2017-08-29 | — | — | CN | claimed |
| WO-2016102177-A1 | HAIR COMPOSITION | UNILEVER PLC (GB) | 2016-06-30 | — | — | WO | claimed |
| WO-2014095289-A2 | METHOD OF TREATING HAIR AGEING | UNILEVER PLC (GB) | 2014-06-26 | — | — | WO | claimed |
| US-20130171104-A1 | SYNERGISTIC ACTIVITY OF MODULATORS OF THE NO METABOLISM AND OF NADPH OXIDASE IN THE SENSITIZATION OF TUMOR CELLS | UNIVERSITAETSKLINIKUM FREIBURG (DE) | 2013-07-04 | — | — | US | claimed |
| JP-3209320-A | — | — | None | — | — | JP | disclosed |
| EP-4663009-A2 | ANTHOCYANIN BIOSYNTHESIS IN CARROT PLANTS | Oterra A/S (DK) | 2025-12-17 | — | — | EP | disclosed |
| EP-4022071-B1 | ANTHOCYANIN BIOSYNTHESIS IN CARROT PLANTS | OTERRA AS (DK) | 2025-10-22 | — | — | EP | disclosed |
| CN-117740961-A | Compound analysis method of liquorice and liquorice probiotics fermentation preparation | 北京中医药大学 | 2024-03-22 | — | — | CN | disclosed |
| US-11744820-B2 | Inhibitors of microbially induced amyloid | AXIAL THERAPEUTICS, INC. (US) | 2023-09-05 | — | — | US | disclosed |
| US-20220275385-A1 | ANTHOCYANIN BIOSYNTHESIS IN CARROT PLANTS | OTERRA A/S (DK) | 2022-09-01 | — | — | US | disclosed |
| WO-1999021006-A9 | PHARMACEUTICAL GRADE VALERIAN, BLACK COHOSH, VITEX AGNUS-CASTUS, BILBERRY AND MILK THISTLE | PHARMAPRINT INC (US) | 1999-07-08 | — | — | WO | disclosed |
| WO-1999021006-A1 | PHARMACEUTICAL GRADE VALERIAN, BLACK COHOSH, VITEX AGNUS-CASTUS, BILBERRY AND MILK THISTLE | PHARMAPRINT, INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| JP-H03209320-A | ANTI-RETROVIRUS AGENT | TORAY IND INC | 1991-09-12 | — | — | JP | disclosed |
| EP-0074505-B1 | FERTILITY INDICATOR SYSTEM | Goldman, Dorothee, F.E. (US) | 1986-11-12 | — | — | EP | disclosed |
| WO-1983001117-A1 | FERTILITY INDICATOR SYSTEM CONTAINING ANTHOCYANIN PIGMENT | GOLDMAN, DOROTHEE, F., E. | 1983-03-31 | — | — | WO | disclosed |
| EP-0074505-A2 | Fertility indicator system | Goldman, Dorothee, F.E. (US) | 1983-03-23 | — | — | EP | disclosed |
| US-4358288-A | Fertility indicator system containing anthocyanin pigment | GOLDMAN, DOROTHEE F.E. | 1982-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11744820-B2 | Inhibitors of microbially induced amyloid | APP, PSEN1, BACE1 | DPP4 1362/4885MAOA 123/4885EGFR 4818/4885 |
| US-20170360673-A1 | HAIR COMPOSITION | GLS2, GLS, CYP17A1 | DPP4 3574/4885MAOA 4622/4885EGFR 1274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.